Entries by omnivance

Opiant Pharmaceuticals, Inc. Announces Listing on the Nasdaq Capital Market

Aug 28, 2017 OTC Disclosure & News Service – SANTA MONICA, Calif., Aug. 28, 2017 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, today announced that its shares of common stock were approved for listing on the Nasdaq Capital Market (“Nasdaq”). Trading on Nasdaq under the […]

Opiant CEO Roger Crystal Appears on Fox News Channel to Discuss the Opioid Crisis Being Declared a National Emergency

Aug 14, 2017 OTC Disclosure & News Service – SANTA MONICA, Calif., Aug. 14, 2017 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, today announced that Roger Crystal, M.D., Chief Executive Officer of Opiant, was interviewed on Friday, August 11, on Fox News Channel. The segment, […]

Opiant Pharmaceuticals, Inc. Announces Additional $3.75 Million Payment From NARCAN® Nasal Spray Royalty Monetization

Aug 10, 2017 OTC Disclosure & News Service – SANTA MONICA, Calif., Aug. 10, 2017 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, today announced that the Company has received an additional $3.75 million payment from SWK Funding LLC, an affiliate of SWK Holdings Corporation (“SWK”), […]

Opiant Pharmaceuticals, Inc. Announces FDA Orange Book Listing for New NARCAN® Nasal Spray Patent

Aug 04, 2017 OTC Disclosure & News Service – SANTA MONICA, Calif., Aug. 04, 2017 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions and eating disorders, today announced that its most recently issued U.S. Patent, No. 9,707,226, covering methods of use for the two-milligram (2mg) formulation […]

FERN Announces Development of Off-Grid Power Storage Device

FOUNTAIN HILLS, Ariz., Aug. 1, 2017 /PRNewswire/ — Fernhill Corporation (OTC PINK: FERN) is pleased to announce the recent development of a new power generation and storage prototype. The first design in a newly launched suite of products will be the “P72” short for “Prototype 72”. After a major disaster, the first 72 hours can […]

Opiant CEO Roger Crystal Appears on Fox & Friends

Jul 27, 2017 OTC Disclosure & News Service – SANTA MONICA, Calif., July 27, 2017 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions and eating disorders, today announced that Roger Crystal, M.D., Chief Executive Officer of Opiant, was featured this morning on Fox & Friends. The […]

Opiant CEO Roger Crystal Appears on Fox Business Network

Jul 26, 2017 OTC Disclosure & News Service – SANTA MONICA, Calif., July 26, 2017 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions and eating disorders, today announced that Roger Crystal, M.D., Chief Executive Officer of Opiant, was interviewed by Maria Bartiromo on Fox Business Network’s […]

KSIX Completes Much Anticipated Agreement with True Wireless

LAS VEGAS, NV — (Marketwired) — 07/24/17 — KSIX Media Holdings, Inc. (OTCBB: KSIX) “The Company”, announced the signed equity agreement with True Wireless. The company will immediately begin managing True Wireless adding over $1.1 million dollars to the company’s monthly revenue. Under the agreement, control of the company has shifted to Brian Cox. Cox […]

Opiant Pharmaceuticals, Inc. Announces Phase I Data for OPNT002 in Development for the Treatment of Alcohol Use Disorder

Jul 19, 2017 OTC Disclosure & News Service – Intravail® Increased the Rate of Absorption of Intranasal Naltrexone No Serious Adverse Events or Evidence of Nasal Irritation Contract Signed with Renaissance to Advance Product Development SANTA MONICA, Calif., July 19, 2017 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological […]

KSIX Media Holdings Announces Shareholder Update-Carter Matzinger, KSIX CEO updates shareholders on True Wireless Merger Transaction and Ongoing Operations

LAS VEGAS, NV — (Marketwired) — 07/17/17 — KSIX Media Holdings, Inc. (OTCBB: KSIX), a diversified media and internet company headquartered in Las Vegas, announce today a shareholder update. Dear Shareholders: I am excited to communicate that KSIX has made significant progress in the merger transaction with True Wireless and growing our core media business. […]